Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review

Abstract About 80 % of all women affected by ovarian cancer present with advanced stage disease at the time of diagnosis. Achieving complete cytoreduction is complicated when many small tumor spots are found. Yet, complete cytoreduction is the most important determinant of survival. Application of a...

Full description

Bibliographic Details
Main Authors: Gatske M. Nieuwenhuyzen-de Boer, Jacoba van der Kooy, Heleen J. van Beekhuizen
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Ovarian Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13048-019-0545-x